Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathis

Showing results (261-270 of 277) with videos related to

Pageof 28
Sort By:
Scientific Reports|December 18, 2023
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cellsTakeshi Kawamata, Arata Wakimoto, Takanobu Nishikawa, et al.
BMC Gastroenterology|September 11, 2010
African-American inflammatory bowel disease in a Southern U.S. health centerHemanth Veluswamy, Kunal Suryawala, Ankur Sheth, et al.
Journal of the National Medical Association|January 7, 2006
Moderate chronic pain, weight and dietary intake in African-American adult patients with sickle cell diseaseJennifer J Pells, Katherine E Presnell, Christopher L Edwards, et al.
World Journal of Surgical Oncology|October 1, 2025
Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancerOsamu Shimomura, Haruko Numajiri, Shinji Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitorJohn I Trujillo, James R Kiefer, Wei Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding modeMarvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Pageof 28

Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Scientific Reports|December 18, 2023
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cellsTakeshi Kawamata, Arata Wakimoto, Takanobu Nishikawa, et al.
BMC Gastroenterology|September 11, 2010
African-American inflammatory bowel disease in a Southern U.S. health centerHemanth Veluswamy, Kunal Suryawala, Ankur Sheth, et al.
Journal of the National Medical Association|January 7, 2006
Moderate chronic pain, weight and dietary intake in African-American adult patients with sickle cell diseaseJennifer J Pells, Katherine E Presnell, Christopher L Edwards, et al.
World Journal of Surgical Oncology|October 1, 2025
Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancerOsamu Shimomura, Haruko Numajiri, Shinji Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitorJohn I Trujillo, James R Kiefer, Wei Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding modeMarvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
Ejhaem|December 18, 2024
Association between microenvironment-related genes and prognosis of primary central nervous system lymphomaKeiichiro Hattori, Kenichi Makishima, Sakurako Suma, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
European Urology|January 18, 2026
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 TrialYoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Pageof 28